GPI-3000

GPI-3000 is a NMDA receptor antagonist. GPI-3000 can ameliorate metabolic injury and shows neuroprotective effect. GPI-3000 can be used for the researches of metabolic and neurological disease[1].

Product Specifications

CAS Number

[144301-37-1]

UNSPSC

12352211

Target

IGluR

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Field of Research

Neurological Disease

Smiles

OC([C@H](N)C[C@@H]1[C@@H](CCCC1)CCP(O)(O)=O)=O

Molecular Formula

C11H22NO5P

Molecular Weight

279.27

References & Citations

[1]Davis S, et al. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs. Stroke. 1997 Jan;28 (1) :198-204; discussion 204-5.